YZi Labs: Condemns CEA Industries' board for adopting a poison pill plan and stripping shareholders of their rights.

YZi Labs is reviewing CEA Industries' response to its written consent solicitation process. These actions include employing a poison pill plan and amending the company's bylaws, aimed at thwarting and delaying shareholder rights. YZi Labs believes the board's actions are intended to consolidate its own power and have already postponed its 2025 annual meeting until after the anniversary on December 17th. Furthermore, YZi Labs refutes CEA Industries' claim that it has never considered an alternative token strategy, pointing out that CEO David Namdar explicitly stated at an industry conference in November 2025 that he was considering a move to assets such as Solana. YZi Labs urges the board to refrain from further actions and to ensure a fair nomination and election process for directors.